November 7, 2025 Asia-Pacific / Biokin / China News / fundraising / healthcare sector / Hong Kong / Industry / Investments / IPO / Market Analysis / pharmaceutical industry / public listing Pharma Company Biokin Considers $432 Million Initial Public Offering in Hong Kong Amid Increased Fundraising Activity Source: ChinaMoneyNetwork.com Continue